Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wu

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Cell Metabolism|June 17, 2023
Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenationYaohua Zhang, Zilong Zhao, Lisa A Huang, et al.
Surgery Open Science|March 24, 2025
Building an international network of young surgeons across surgical specialties - Introducing the Young Surgeons Publications CommitteeLouisa Bolm, Martina Nebbia, Thomas F Stoop, et al.
Science Translational Medicine|November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditisYaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances|February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusionChengcao Sun, Youqiong Ye, Zhi Tan, et al.
British Journal of Cancer|May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Cell Metabolism|June 17, 2023
Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenationYaohua Zhang, Zilong Zhao, Lisa A Huang, et al.
Surgery Open Science|March 24, 2025
Building an international network of young surgeons across surgical specialties - Introducing the Young Surgeons Publications CommitteeLouisa Bolm, Martina Nebbia, Thomas F Stoop, et al.
Science Translational Medicine|November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditisYaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances|February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusionChengcao Sun, Youqiong Ye, Zhi Tan, et al.
British Journal of Cancer|May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
Pageof 15